Recalled by GSK, acidity drug accused of causing cancer still sells in India. Blame varying test results.
A study in the US has found 3,000 times higher carcinogen content in anti-acidity drug ranitidine. But it’s business as usual in India. While GSK and Dr. Reddy’s have recalled the drug globally, Cadila Pharma and JB Chemicals say they will continue to sell it as their internal tests have shown that the presence of N-DMA in their products is within permissible limits.